Sage Therapeutics

Cassava Sciences

Harmony Biosciences

Denali Therapeutics

Neurocrine Biosciences

ACADIA Pharmaceuticals

Praxis Precision Medicine

Axsome Therapeutics

Alector Inc

SAGE-718 — Huntington's disease cognitive impairment

Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices

Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET)

National Pregnancy Registry for Psychiatric Medications

S.T.A.N.D. Alacrity Center Signature Project

Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD

SAGE (safer analgesia): a protocol for a pragmatic cluster randomised controlled trial to reduce the use of high-risk medicines in people with chronic back and/or neck pain.

The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD(✰).

Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Adjunctive Antipsychotics in Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.

Development of a decision aid to help dually enrolled veterans make informed choices on medication sourcing.

The Lancet Commission on Sepsis: transforming sepsis care and outcomes.

Foslevodopa/Foscarbidopa Subcutaneous Infusion Safety and Efficacy in Patients with and Without Prior Deep Brain Stimulation.

SW convergence: 50/100 (Neutral), 0 bullish / 0 bearish signals

The cost-effectiveness of predictive algorithm guided primary antidepressant treatment: economic evaluation of the multinational PReDicT randomised controlled trial.

Botulinum toxin injection induced autoimmune thyroiditis and myxedema coma: A case report.

Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress.

The Clinically Meaningful Score Difference and Meaningful Score Regions in Positive and Negative Syndrome Scale Total Score from Post Hoc Analyses of a Phase 3 Pivotal Clinical Trial of Transdermal Asenapine in Patients with Schizophrenia.

Evaluation of Chitosan-Pimelate Buccal Film Loaded with Duloxetine-Modified Sage Lipid Carriers Nanoformulation for Effective Antidepressant Activity in a Rat Model.

<article class="bts-verified-summary" data-ticker="SAGE">
<p>Sage Therapeutics (SAGE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>SAGE has 1 Form 4 insider filing recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22SAGE%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

SEC EDGAR

Sage Therapeutics (SAGE) — BioTechSigns Verified Summary

Sage Therapeutics (SAGE) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

SAGE has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22SAGE%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11